Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention...

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Risk Stratification

Background:

• No-reflow phenomenon is a critical adverse event during percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).
• Predicting no-reflow before reperfusion is crucial for optimizing patient outcomes.
• Existing risk assessment methods may lack simplicity or pre-procedural applicability.

Purpose of the Study:

• To develop and validate a simple risk score system for identifying STEMI patients at high risk of developing no-reflow.
• To enable pre-reperfusion risk stratification in STEMI patients undergoing PCI.

Main Methods:

• A cohort of 173 STEMI patients undergoing primary or rescue PCI was analyzed.
• Patients were categorized into no-reflow and non-no-reflow groups.
• Univariate and multivariate logistic regression identified independent predictors of no-reflow, including pre-procedural ECG, laboratory parameters, demographics, and treatment times. A risk score was derived.

Main Results:

• Independent predictors for no-reflow were identified as high blood glucose, long symptom-onset-to-balloon time, and low lymphocyte count.
• No-reflow incidence was 13.3% (low risk), 40.0% (moderate risk), and 46.7% (high risk).
• The developed risk score demonstrated good predictive performance with a c-statistic of 0.734.

Conclusions:

• A simple clinical risk scoring method can effectively predict the development of no-reflow in STEMI patients.
• This tool offers an efficient way to identify high-risk individuals before reperfusion therapy.
• The risk score facilitates improved clinical decision-making and patient management in STEMI.